GNC and Harbin Pharmaceutical Announce $300 Million Strategic Investment and China Joint Venture

Creates long-term strategic global partnership and establishes platform for accelerated growth in ChinaEnhances GNC’s capital positionGNC also announces plans to…

You must be a paid subscriber to view this content. To become a new paid subscriber, please go to the REGISTER TAB and choose one of the subscription plans.

error: Content is protected !!
en_USEnglish
en_USEnglish